Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Luye Pharma Group Limited Earnings Release 2004

Jul 23, 2004

50431_rns_2004-07-23_56a2e778-2a1b-40fb-9c47-6cd4302ef7e4.htm

Earnings Release

Open in viewer

Opens in your device viewer

Listed Company Information

Listed Company Information
TAKSON HOLDINGS<00918> - Results Announcement

Takson Holdings Limited announced on 23/07/2004:
(stock code: 00918 )
Year end date: 31/03/2004
Currency: HKD
Auditors' Report: Unqualified

(Audited )
(Audited ) Last
Current Corresponding
Period Period
from 01/04/2003 from 01/04/2002
to 31/03/2004 to 31/03/2003
Note ('000 ) ('000 )
Turnover : 208,185 258,701
Profit/(Loss) from Operations : (15,270) 3,741
Finance cost : (2,461) (2,661)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : N/A N/A
Profit/(Loss) after Tax & MI : (17,472) 1,662
% Change over Last Period : N/A %
EPS/(LPS)-Basic (in dollars) : (0.045) 0.004
-Diluted (in dollars) : N/A N/A
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : (17,472) 1,662
Final Dividend : NIL NIL
per Share
(Specify if with other : N/A N/A
options)

B/C Dates for
Final Dividend : N/A
Payable Date : N/A
B/C Dates for (-)
General Meeting : N/A
Other Distribution for : N/A
Current Period

B/C Dates for Other
Distribution : N/A

Remarks:

Notes:

(1) (Loss)/ earnings per share

The calculation of basic (loss)/ earnings per share is based on the Group's loss
attributable to shareholders of approximately HK$17,472,000 (2003: profit of
approximately HK$1,662,000).

The basic (loss)/ earnings per share is based on the weighted average number of
389,500,000 (2003: 389,500,000) ordinary shares in issue during the year. No diluted
(loss)/ earnings per share is presented as there are no dilutive potential ordinary
shares for the years ended 31st March, 2004 and 2003.